Current perspectives on rosuvastatin
Miao Hu, Brian Tomlinson Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin, Hong Kong Abstract: Rosuvastatin is one of the most potent statins available for reducing circulating low-density lipoprotein cholesterol (LDL-C) levels, which enables more high-risk patients t...
Main Authors: | Hu M, Tomlinson B |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-04-01
|
Series: | Integrated Blood Pressure Control |
Online Access: | http://www.dovepress.com/current-perspectives-on-rosuvastatin-a12803 |
Similar Items
-
Combination Therapy of Ezetimibe and Rosuvastatin for Dyslipidemia: Current Insights
by: Chilbert MR, et al.
Published: (2022-07-01) -
Optimization of UPLC method for simultaneous determination of rosuvastatin and rosuvastatin degradation products
by: Jure Zakrajšek, et al.
Published: (2017-12-01) -
The farnesoid X receptor -1G>T polymorphism influences the lipid response to rosuvastatin
by: Miao Hu, et al.
Published: (2012-07-01) -
Perioperative rosuvastatin in cardiac surgery
by: Zheng, Z, et al.
Published: (2016) -
Rosuvastatin-Induced reversible rhabdomyolysis
by: Sangeeta Pradhan, et al.
Published: (2023-01-01)